会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 83. 发明授权
    • Process for producing activated carbon for electrode of electric double-layer capacitor, and carbon material
    • 生产双电层电容器用电极活性炭及碳材料的方法
    • US06660583B2
    • 2003-12-09
    • US10152989
    • 2002-05-23
    • Takeshi FujinoShigeki OyamaKenji SatoMinoru Noguchi
    • Takeshi FujinoShigeki OyamaKenji SatoMinoru Noguchi
    • H01L218242
    • H01G11/34C01B32/342H01G9/155H01G11/04Y02E60/13
    • Activated carbon for an electrode of an electric double-layer capacitor is produced by subjecting a carbon material sequentially to a carbonizing treatment and an alkali activating treatment, and by using a carbon material. The carbon material used is a condensed polycyclic aromatic compound (CPAC) which has a condensed ring (CR) and at least one aliphatic hydrocarbon radical (R) bonded to said condensed ring (CR). The condensed ring (CR) includes at least one alicyclic hydrocarbon structure moiety (ALC). In an analysis chart resulting from a 13C-NMR spectroscopy of the condensed polycyclic aromatic compound, a signal intensity ratio IL/IR is equal to or larger than 0.2, and a signal intensity ratio IC/IR is equal to or larger than 0.14, wherein IR represents a signal intensity of an aromatic peak; IL represents a signal intensity of an aliphatic hydrocarbon peak; and IC represents a signal intensity of an alicyclic hydrocarbon peak. Thus, activated carbon of a low electrostatic capacity revealing voltage and a high electrostatic capacity density (F/cc) can be produced by using a particular carbon material.
    • 通过使碳材料依次进行碳化处理和碱激活处理,并且使用碳材料来制造双电层电容器的电极的活性炭。 所使用的碳材料是具有稠环(CR)和至少一个与所述稠环(CR)键合的脂族烃基(R)的缩合多环芳族化合物(CPAC)。 稠环(CR)包括至少一个脂环族烃结构部分(ALC)。 在由缩合多环芳族化合物的13 C-NMR光谱产生的分析图中,信号强度比IL / IR等于或大于0.2,信号强度比IC / IR等于或大于 0.14,其中IR表示芳族峰的信号强度; IL表示脂肪族烃峰的信号强度; IC表示脂环烃峰的信号强度。 因此,可以通过使用特定的碳材料来制造显示电压低和静电容量密度高(F / cc)的低静电容量的活性炭。
    • 85. 发明授权
    • RAS monitor circuit and field memory using the same
    • RAS监控电路和现场存储器使用相同
    • US06345002B1
    • 2002-02-05
    • US09667683
    • 2000-09-22
    • Kenji SatoOsamu Kuroki
    • Kenji SatoOsamu Kuroki
    • G11C700
    • G11C11/4076G11C7/22
    • A field memory includes a DRAM core, a processor that generates and supplies a RAS control signal to the DRAM core, and a RAS cycle monitor circuit. The RAS cycle monitor circuit includes a counter circuit that counts the number of cycles of a RAS control signal supplied to a DRAM core in a predetermined period of time, and a monitor circuit that detects whether the number of cycles of the RAS control signal is within a normal operating range. The monitor circuit supplies a monitor output signal to indicate whether the RAS control signal is being generated on a proper cycle.
    • 场存储器包括DRAM内核,产生并向DRAM内核提供RAS控制信号的处理器,以及RAS周期监视电路。 RAS周期监视电路包括计数器电路,其在预定时间段内对提供给DRAM内核的RAS控制信号的周期数进行计数;以及监视电路,其检测RAS控制信号的周期数是否在 正常工作范围。 监视器电路提供监视器输出信号以指示RAS控制信号是否正在适当的周期上产生。
    • 89. 发明授权
    • Substituted benzoylaminothiazole derivatives and drugs containing the
same
    • 取代苯甲酰氨基噻唑衍生物和含有它们的药物
    • US6121301A
    • 2000-09-19
    • US284477
    • 1999-04-21
    • Masaaki NagasawaKenji SatoTadashi KurimotoShigeru Ueki
    • Masaaki NagasawaKenji SatoTadashi KurimotoShigeru Ueki
    • C07D277/46C07D277/56C07D417/12A61K31/425
    • C07D417/12C07D277/46C07D277/56
    • The present invention relates to a substituted benzoylaminothiazole derivative represented by the following formula (I): ##STR1## wherein X represents an imino group which may be substituted by a lower alkyl group, or an oxygen atom, R.sup.1 represents a cyano group, a lower alkoxycarbonyl group, a lower alkoxycarbonylamino group, a lower alkylsulfonylamino group, a lower alkanoyl or lower alkylsulfonyl group which may be substituted by a halogen atom, a 1-ureido group, a halo-substituted lower alkyl group or a 2-pyrrolylimino group, R.sup.2 and R.sup.3 are the same or different and each independently represents a hydrogen atom or a lower alkyl group and m stands for an integer of 2 to 4, or a salt thereof; and a medicament comprising the compound as an effective ingredient. The compound of the invention is useful as a preventive and therapeutic agent for epigastric dyscomfort, nausea, vomiting, heartburn, anorexia, bellyache, abdominal flatulence, chronic gastritis or the like.
    • PCT No.PCT / JP97 / 03774 Sec。 371 1999年4月21日第 102(e)1999年4月21日PCT PCT 1997年10月20日PCT公布。 公开号WO98 / 17654 日期:1998年04月30日本发明涉及由下式(I)表示的取代苯甲酰氨基噻唑衍生物:其中X表示可被低级烷基或氧原子取代的亚氨基,R 1表示氰基, 低级烷氧基羰基,低级烷氧基羰基氨基,低级烷基磺酰基氨基,可被卤素原子取代的低级烷酰基或低级烷基磺酰基,1-脲基,卤代低级烷基或2-吡咯基咪唑基 ,R2和R3相同或不同,各自独立地表示氢原子或低级烷基,m表示2〜4的整数,或其盐; 以及包含该化合物作为有效成分的药物。 本发明的化合物可用作上腹部不适,恶心,呕吐,胃灼热,厌食,腹痛,腹胀气,慢性胃炎等的预防和治疗剂。